We are live on ! Find out more
AC

Amia Capital Portfolio holdings

AUM $32.1M
1-Year Est. Return 0.56%
This Fund
S&P 500
This Quarter Est. Return
+22.35%
1 Year Est. Return
+0.56%
3 Year Est. Return
+30.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$122M
AUM Growth
+$9.23M
Cap. Flow
+$3.04M
Cap. Flow %
2.5%
Top 10 Hldgs %
87.08%
Holding
43
New
3
Increased
3
Reduced
32
Closed
5

Top Buys

Rank Stock Value
1
PBR icon
Petrobras
PBR
+$7.54M
2
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$7.23M
3
LSXMK
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
+$5.21M
4
FATE icon
Fate Therapeutics
FATE
+$204K
5
BDTX icon
Black Diamond Therapeutics
BDTX
+$180K

Top Sells

Rank Stock Value
1
LILA icon
Liberty Latin America Class A
LILA
+$4.88M
2
LSXMA
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
+$4.55M
3
GRFS
Grifois
GRFS
+$4.49M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$1.36M
5
MRNA icon
Moderna
MRNA
+$1.09M

Sector Composition

Rank Sector Weight
1 Healthcare 42.65%
2 Energy 7.14%
3 Materials 2.97%
4 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRFS
1
Grifois
GRFS
$5.27B
$28.8M 23.64%
1,577,297
-226,559
-13% -$4.49M
LSXMK
2
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$19.4M 15.9%
725,138
+202,539
+39% +$5.21M
LSXMA
3
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$18.9M 15.51%
743,948
-185,834
-20% -$4.55M
BBL
4
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$17.6M 14.46%
427,696
+198,777
+87% +$7.23M
PBR icon
5
Petrobras
PBR
$119B
$8.68M 7.14%
1,050,000
+1,040,000
+10,400% +$7.54M
VALE icon
6
Vale
VALE
$60.6B
$3.61M 2.97%
350,000
-100,000
-22% -$915K
IONS icon
7
Ionis Pharmaceuticals
IONS
$8.82B
$2.67M 2.19%
45,199
-24,479
-35% -$1.36M
NBIX icon
8
Neurocrine Biosciences
NBIX
$18B
$2.23M 1.83%
18,299
-9,840
-35% -$1.09M
VRTX icon
9
Vertex Pharmaceuticals
VRTX
$122B
$2.13M 1.75%
7,351
-3,458
-32% -$938K
INCY icon
10
Incyte
INCY
$23.5B
$2.06M 1.69%
19,792
-9,843
-33% -$949K
MRNA icon
11
Moderna
MRNA
$23.7B
$1.42M 1.16%
22,048
-19,945
-47% -$1.09M
ALNY icon
12
Alnylam Pharmaceuticals
ALNY
$36.2B
$1.39M 1.14%
9,404
-4,542
-33% -$612K
HALO icon
13
Halozyme
HALO
$9.32B
$1.23M 1.01%
45,934
-23,475
-34% -$530K
ARGX icon
14
argenx
ARGX
$54.7B
$1.2M 0.98%
5,316
-2,919
-35% -$518K
AGIO icon
15
Agios Pharmaceuticals
AGIO
$2.22B
$1.18M 0.97%
22,096
-11,862
-35% -$549K
ESPR
16
DELISTED
Esperion Therapeutics
ESPR
$1.07M 0.88%
20,903
-11,589
-36% -$485K
ALXN
17
DELISTED
Alexion Pharmaceuticals
ALXN
$836K 0.69%
7,447
-4,005
-35% -$425K
MGNX icon
18
MacroGenics
MGNX
$289M
$709K 0.58%
25,403
-13,986
-36% -$243K
MYOK
19
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$687K 0.56%
7,109
-3,910
-35% -$326K
IBB icon
20
iShares Biotechnology ETF
IBB
$9.37B
$686K 0.56%
5,015
-6,192
-55% -$789K
ITCI
21
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$657K 0.54%
25,602
-4,542
-15% -$91.9K
MYOV
22
DELISTED
Myovant Sciences Ltd.
MYOV
$558K 0.46%
27,070
-14,900
-36% -$203K
RDUS
23
DELISTED
Radius Health, Inc.
RDUS
$525K 0.43%
38,551
-21,432
-36% -$295K
QQQ icon
24
CALL
Invesco QQQ Trust
QQQ
$471B
$468K 0.38%
+46,800
New +$10.5M
EXEL icon
25
Exelixis
EXEL
$14.1B
$378K 0.31%
15,943
-8,769
-35% -$203K
1
2

Similar funds

QI
Qualcomm Inc San Diego, California $32.1M AUM 5.35% 1-Year Est. Return
SAM
Sandbar Asset Management London, United Kingdom $30.5M AUM 46.07% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
AG
Appleton Group Appleton, Wisconsin $28.6M AUM 32.21% 1-Year Est. Return
NLG
New Legacy Group New York $36.6M AUM 36.77% 1-Year Est. Return
BEVI
Braemar Energy Ventures III New York $37.9M AUM 66.45% 1-Year Est. Return
BGDR
BC Gestao de Recursos Sao Paulo, Brazil $38.2M AUM
TAAM
Top Ace Asset Management Hong Kong $25.3M AUM 23.27% 1-Year Est. Return

Amia Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Amia Capital held 43 positions worth $122M, up 8.2% from $112M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Amia Capital's Q2 2020 filing shows 3 new, 3 increased, 32 reduced and 5 closed positions. Its largest new stake was Fate Therapeutics: 6,838 shares worth $235K. The largest sale was Liberty Latin America Class A, an estimated $4.88M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 54% a quarter earlier, followed by Energy and Materials.

  • Amia Capital's largest Q2 2020 buy was Fate Therapeutics: 6,838 shares worth $235K.
  • Amia Capital added most to Petrobras in Q2 2020, an estimated $7.54M increase.
  • Amia Capital's biggest Q2 2020 reduction was Liberty Media Corporation Series A Liberty SiriusXM Common Stock, cutting an estimated $4.55M.
  • Amia Capital fully exited Liberty Latin America Class A in Q2 2020, selling an estimated $4.88M.
  • Amia Capital's ten largest holdings make up 87% of its $122M portfolio in Q2 2020.
  • Amia Capital opened 3 new positions and closed 5 in Q2 2020.
  • Amia Capital's portfolio value rose 8.2% quarter-over-quarter to $122M.

Based on Amia Capital's 13F filing for Q2 2020, filed 14 Aug 2020.